<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Mycology, pathogenesis, and epidemiology of Fusarium infection</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Mycology, pathogenesis, and epidemiology of Fusarium infection</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Mycology, pathogenesis, and epidemiology of Fusarium infection</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Marcio Nucci, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elias Anaissie, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carol A Kauffman, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Keri K Hall, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 27, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span><em>Fusarium</em> species cause a broad spectrum of infections in humans including superficial infections, such as keratitis and onychomycosis, as well as locally invasive and disseminated infections; invasive and disseminated infections occur almost exclusively in severely immunocompromised patients [<a href="#rid1">1</a>]. <em>Fusarium</em> species may also cause allergic diseases, such as sinusitis in immunocompetent individuals [<a href="#rid2">2</a>], and mycotoxicosis following ingestion of food contaminated by toxin-producing <em>Fusarium</em> species [<a href="#rid3">3</a>]. <em>Fusarium</em> species are also important plant pathogens that cause various diseases on cereal grains [<a href="#rid3">3</a>] and occasionally cause infection in animals [<a href="#rid4">4</a>].</p><p>The mycology, pathogenesis, and epidemiology of fusariosis will be reviewed here. The clinical manifestations, diagnosis, treatment, and prevention of fusariosis are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/16218.html" rel="external">"Clinical manifestations and diagnosis of Fusarium infection"</a> and  <a class="medical medical_review" href="/z/d/html/15674.html" rel="external">"Treatment and prevention of Fusarium infection"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">MYCOLOGY</span><span class="headingEndMark"> — </span><em>Fusarium</em> species are widely distributed in soil, subterranean and aerial plant parts, plant debris, and other organic matter [<a href="#rid3">3</a>]. They are also present in water worldwide [<a href="#rid5">5</a>].</p><p class="headingAnchor" id="H516901989"><span class="h2">Growth in vitro</span><span class="headingEndMark"> — </span><em>Fusarium</em> species grow rapidly on many media that do not contain cycloheximide, which inhibits its growth. On potato dextrose agar, <em>Fusarium </em>species produce white-, lavender-, pink-, salmon-, or gray-colored colonies with velvety or cottony surfaces [<a href="#rid6">6</a>].</p><p class="headingAnchor" id="H516902309"><span class="h2">Microscopic appearance</span><span class="headingEndMark"> — </span>Microscopically, the hyphae of <em>Fusarium</em> in tissue resemble those of <em>Aspergillus</em> species, with septate hyaline hyphae 3 to 8 microns in diameter that typically branch at acute angles  (<a class="graphic graphic_picture graphicRef69801" href="/z/d/graphic/69801.html" rel="external">picture 1</a> and <a class="graphic graphic_picture graphicRef74308" href="/z/d/graphic/74308.html" rel="external">picture 2</a>). Adventitious sporulation, which is the ability to sporulate in tissue and blood, may be present [<a href="#rid7">7</a>]; the identification of hyphal and yeast-like structures in the same specimen is highly suggestive of fusariosis in high-risk patients.</p><p>In cultures, the production of both fusoid macroconidia (hyaline, multicellular, banana-like clusters with foot cells at the base)  (<a class="graphic graphic_picture graphicRef72385" href="/z/d/graphic/72385.html" rel="external">picture 3</a> and <a class="graphic graphic_picture graphicRef61073" href="/z/d/graphic/61073.html" rel="external">picture 4</a>) and microconidia (hyaline, unicellular, ovoid to cylindrical) are characteristic of the genus <em>Fusarium</em>.</p><p class="headingAnchor" id="H516901982"><span class="h2">Species identification</span><span class="headingEndMark"> — </span>The characteristic appearance of <em>Fusarium </em>macroconidia can be used for identification  (<a class="graphic graphic_picture graphicRef72385" href="/z/d/graphic/72385.html" rel="external">picture 3</a> and <a class="graphic graphic_picture graphicRef61073" href="/z/d/graphic/61073.html" rel="external">picture 4</a>), but species identification is difficult and often requires molecular methods [<a href="#rid8">8-10</a>]. Mass spectrometry using matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) has been shown to correctly identify clinical isolates to the species level [<a href="#rid11">11,12</a>]. </p><p class="headingAnchor" id="H19276811"><span class="h2">Species prevalence</span><span class="headingEndMark"> — </span>More than 300 species of <em>Fusarium</em> have been identified, but only a few cause infections in humans [<a href="#rid13">13,14</a>]. Fusarium species are grouped into &gt;20 phylogenetic species complexes, 7 of which have been reported to cause significant human disease [<a href="#rid15">15</a>]: <em>Fusarium solani </em>species complex (FSSC), <em>Fusarium oxysporum </em>species complex (FOSC), <em>Fusarium fujikuroi </em>species complex (FFSC), <em>Fusarium incarnatum-equiseti </em>species complex, <em>Fusarium chlamidosporum </em>species complex, <em>Fusarium dimerum </em>species complex, and <em>Fusarium sporotrichoides </em>species complex, with various species within each complex. Approximately 50 percent of cases of invasive fusariosis are caused by FSSC, followed by FOSC and FFSC [<a href="#rid1">1,16</a>]. The distribution of species causing infection varies geographically. For example, in Brazil FSSC is the predominant species complex [<a href="#rid17">17</a>], whereas in various European countries FFSC is the most frequent (especially <em>Fusarium verticillioides </em>and <em>Fusarium proliferatum</em>) [<a href="#rid18">18</a>]. Fusarial keratitis is most commonly caused by FSSC [<a href="#rid19">19</a>], while fusarial onychomycosis is most commonly caused by <em>F. oxysporum</em> [<a href="#rid20">20-22</a>].</p><p class="headingAnchor" id="H524569980"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span><em>Fusarium</em> spp cause invasive disease by angioinvasion and direct tissue destruction [<a href="#rid3">3,23</a>]. <em>Fusarium</em> species possess several virulence factors including mycotoxins, which suppress humoral and cellular immunity and can also cause allergic reactions [<a href="#rid3">3</a>]. <em>Fusarium</em> spp also have the ability to adhere to prosthetic material [<a href="#rid3">3</a>] and to produce proteases and collagenases [<a href="#rid24">24</a>]. <em>F. solani</em> is thought to be the most virulent <em>Fusarium</em> species [<a href="#rid25">25</a>]. Some <em>Fusarium</em> species produce mycotoxins that are destructive to crops and can cause human disease when ingested with heavily contaminated grains [<a href="#rid21">21</a>].</p><p class="headingAnchor" id="H524570005"><span class="h2">Immune response</span><span class="headingEndMark"> — </span>Innate immunity plays a major role in the defense against <em>Fusarium</em> species [<a href="#rid26">26</a>]. Macrophages and neutrophils damage fusarial hyphae, and their effect is primed by interferon-gamma, granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor [<a href="#rid27">27</a>], and interleukin (IL)-15 [<a href="#rid28">28</a>]. The effect of IL-15 is mediated by the release of IL-8 and by direct stimulation of hyphal damage. The role of toll-like receptors in the innate immune recognition of fungi is increasingly being recognized [<a href="#rid29">29</a>], and, although little is known about fusariosis and toll-like receptors, this system is likely to be important in invasive fusariosis.</p><p class="headingAnchor" id="H4"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span><em>Fusarium</em> species cause a broad spectrum of infections in humans, including superficial, locally invasive, and disseminated infections. The clinical form of infection depends upon the immune status of the host and the portal of entry of the pathogen [<a href="#rid1">1</a>].</p><p class="headingAnchor" id="H473991960"><span class="h2">Immunocompetent hosts</span><span class="headingEndMark"> — </span>Keratitis and onychomycosis are the most common infections in immunocompetent patients. Other sites of infection have also been reported  (<a class="graphic graphic_table graphicRef64555" href="/z/d/graphic/64555.html" rel="external">table 1</a>) [<a href="#rid30">30-42</a>].</p><p class="headingAnchor" id="H420413563"><span class="h3">Keratitis</span><span class="headingEndMark"> — </span><em>Fusarium</em> spp are a common cause of fungal keratitis, which may develop following the traumatic introduction of <em>Fusarium</em>-contaminated soil or plant material or due to poor hygiene practices of soft contact lens wearers, particularly in patients using glucocorticoid eye drops. A large international outbreak of fusarial keratitis between 2004 and 2006 was linked to the use of a specific contact lens solution (ReNu with MoistureLoc) [<a href="#rid43">43-47</a>]. The solution was not intrinsically contaminated. One study has suggested that in the setting of storage at high temperatures, the antimicrobial agent in the solution, alexidine dihydrochloride, permeates the walls of the plastic bottle, resulting in decreased concentrations in the solution [<a href="#rid48">48</a>]. The fungicidal action of the solution was diminished, allowing <em>Fusarium</em> that had been introduced by the wearer while caring for his or her lenses to grow and contaminate the contact lens and the lens case. The solution was recalled in the United States in 2006, and rates of contact lens-associated <em>Fusarium</em> keratitis have declined since then [<a href="#rid49">49</a>].</p><p>The incidence of fungal keratitis caused by <em>Fusarium</em> species is highly variable and depends largely upon the geographic location. For example, in several studies performed at different times over a span of 10 years, the incidence has been noted to range from 8 percent in India to 25 percent in Pennsylvania, 63 percent in Florida, and 75 percent in Tanzania [<a href="#rid19">19,50,51</a>]. These variable rates are probably related to climate characteristics, with tropical and subtropical areas exhibiting the highest rates [<a href="#rid19">19</a>].</p><p class="headingAnchor" id="H420413570"><span class="h3">Onychomycosis</span><span class="headingEndMark"> — </span><em>Fusarium</em> species have been reported as agents of onychomycosis with increasing frequency among immunocompetent individuals [<a href="#rid52">52,53</a>] with variable rates reported from different regions. As an example, in a study from central Italy, fewer than 2 percent of cases of onychomycosis were caused by <em>Fusarium</em> spp [<a href="#rid54">54</a>], compared with more than 8 percent in a study of onychomycosis cases from the northeast region of Brazil [<a href="#rid20">20</a>].</p><p class="headingAnchor" id="H293415890"><span class="h3">Meningitis</span><span class="headingEndMark"> — </span>Although rare, <em>Fusarium </em>meningitis has been reported from health care-associated sources. Two separate outbreaks have occurred, one in late 2022 and another between January 1 and May 13, 2023, among individuals who underwent epidural anesthesia for plastic surgery procedures performed at specific clinics in Durango and Matamoros, Mexico [<a href="#rid55">55,56</a>]. (See  <a class="medical medical_review" href="/z/d/html/1296.html" rel="external">"Aseptic meningitis in adults", section on 'Fusarium outbreaks'</a>.)</p><p class="headingAnchor" id="H473991967"><span class="h2">Immunocompromised patients</span></p><p class="headingAnchor" id="H524570268"><span class="h3">Portals of entry</span><span class="headingEndMark"> — </span>Invasive fusariosis has been reported worldwide and may be acquired both in the community and in the hospital setting. The principal modes of infection are airborne or via direct inoculation at various sites (skin and others) of <em>Fusarium</em>-contaminated material, including water  (<a class="graphic graphic_table graphicRef57202" href="/z/d/graphic/57202.html" rel="external">table 2</a>). Airborne infection typically results from the inhalation of fusarial conidia from the air [<a href="#rid57">57</a>], but in some cases have been associated with aerosolization of conidia from a water source [<a href="#rid58">58</a>]. In addition, pre-existing skin breakdown or onychomycosis may facilitate direct introduction of <em>Fusarium</em> spp. An increase in cases of invasive fusariosis with a cutaneous portal of entry has been reported in Brazil [<a href="#rid59">59</a>]. Onychomycosis and intertrigo were the predominant primary lesions. A subsequent study from the same group showed that in hematologic patients at high risk of developing invasive fusariosis, the presence of such lesions growing <em>Fusarium</em> spp at the time of admission increased the risk for the subsequent occurrence of invasive disease [<a href="#rid60">60</a>].</p><p>Central venous catheter-related <em>Fusarium</em> infection has also been reported; in one report, 7 cases of genetically related <em>F. oxysporum</em> bloodstream infection occurred in children with cancer who had central venous catheters [<a href="#rid61">61</a>]. Although an environmental source was not identified, the outbreak was presumed to be due to central line manipulation in a specific room as the outbreak ended after implementation of a multidisciplinary central line insertion care bundle.</p><p class="headingAnchor" id="H524570275"><span class="h3">Risk factors</span><span class="headingEndMark"> — </span>Patients with compromised immune function are at increased risk for invasive fusariosis, particularly in the setting of prolonged and profound neutropenia and/or severe T cell immunodeficiency [<a href="#rid62">62</a>]. Unlike infection in normal hosts, fusariosis in the immunocompromised population is typically invasive and disseminated [<a href="#rid30">30</a>].</p><p>The overall incidence of fusariosis among hematopoietic cell transplant (HCT) recipients and patients with acute myeloid leukemia (AML) is low, usually less than 1 percent, as reported in studies conducted in the United States and Italy [<a href="#rid63">63-65</a>]. By contrast, in a multicenter study conducted between 2007 and 2009 in Brazil, invasive fusariosis was the second most common cause of invasive fungal disease among patients with AML (3.8 percent) and the most common cause among allogeneic HCT recipients (5.2 percent) [<a href="#rid66">66</a>]. In a more recent study from Brazil, invasive fusariosis was the third most-frequent invasive fungal disease among patients with hematologic cancers (3 cases among 192 patients [1.6 percent]) [<a href="#rid67">67</a>]. These geographic differences in the incidence of invasive fusariosis must be taken into account in the management of high-risk patients.</p><p>Among patients with hematologic malignancy, the infection predominates during periods of neutropenia, typically among patients with leukemia receiving induction chemotherapy [<a href="#rid68">68</a>]. Smoking also appears to be a risk factor in patients with AML or myelodysplastic syndrome [<a href="#rid69">69</a>]. <a class="drug drug_general" data-topicid="91587" href="/z/d/drug information/91587.html" rel="external">Ibrutinib</a>, a Bruton tyrosine kinase inhibitor, has been associated with invasive fungal infections, including invasive fusariosis [<a href="#rid70">70</a>]. (See  <a class="medical medical_review" href="/z/d/html/95716.html" rel="external">"Risk of infections in patients with chronic lymphocytic leukemia", section on 'Bruton tyrosine kinase inhibitors'</a>.)</p><p>Invasive fusariosis also occurs with an increased frequency among allogeneic HCT recipients in whom a trimodal distribution of infection has been identified [<a href="#rid71">71</a>]. The first peak occurs during the first 30 days following transplantation and is associated with neutropenia. Severe T cell immunodeficiency (but not neutropenia) is the major risk factor for fusariosis that develops after engraftment and which occurs at a median of 70 days after HCT, commonly in the setting of acute graft-versus-host disease (GVHD) and therapy with glucocorticoids. The third peak is observed &gt;1 year after HCT during treatment for extensive chronic GVHD. In one study, risk factors for invasive fusariosis during the early phase following allogeneic HCT included receipt of antithymocyte globulin, hyperglycemia, and AML [<a href="#rid69">69</a>]. During the late phase following allogeneic HCT, risk factors included nonmyeloablative conditioning regimen, grade III/IV GVHD, and previous invasive mold disease.</p><p>The prognosis of fusariosis is directly related to the patient's immune status, with high death rates in patients with persistent immunodeficiencies. In a series of 84 patients with fusariosis and an underlying hematologic malignancy, persistent neutropenia and recent glucocorticoid therapy were the only independent factors associated with poor outcome [<a href="#rid68">68</a>]. (See  <a class="medical medical_review" href="/z/d/html/15674.html" rel="external">"Treatment and prevention of Fusarium infection", section on 'Prognosis'</a>.)</p><p>Locally invasive <em>Fusarium</em> infections occur occasionally among solid organ transplant recipients, typically during the late post-transplant period; disseminated infections have been reported rarely in such patients [<a href="#rid72">72</a>]. Cases of chronic cutaneous fusariosis have also been reported in patients with STAT3 Hyper-IgE Syndrome [<a href="#rid73">73</a>].</p><p>Invasive fungal disease has also been reported in previously immunocompetent individuals who developed severe forms of COVID-19. While most infections were caused by aspergillosis, cases of invasive fusariosis were also reported [<a href="#rid74">74</a>]. The use of glucocorticosteroids for the treatment of severe COVID-19 pneumonia is thought to contribute to the development of these fungal infections [<a href="#rid74">74</a>].</p><p>The clinical manifestations of fusariosis are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/16218.html" rel="external">"Clinical manifestations and diagnosis of Fusarium infection"</a>.)</p><p class="headingAnchor" id="H22"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Spectrum of disease</strong> – <em>Fusarium</em> species are important plant pathogens that cause various diseases on cereal grains and occasionally cause infection in animals. In humans, <em>Fusarium</em> species cause a broad spectrum of infections including superficial infections, such as keratitis and onychomycosis, as well as locally invasive and disseminated infections; invasive and disseminated infections occur almost exclusively in severely immunocompromised patients. (See <a class="local">'Introduction'</a> above and  <a class="medical medical_review" href="/z/d/html/16218.html" rel="external">"Clinical manifestations and diagnosis of Fusarium infection"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reservoir</strong> – <em>Fusarium</em> species are widely distributed in soil, subterranean and aerial plant parts, plant debris, and other organic matter. They are also present in water. (See <a class="local">'Mycology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiology</strong> – Microscopically, the hyphae of <em>Fusarium</em> in tissue resemble those of <em>Aspergillus</em> species, with septate hyaline hyphae 3 to 8 microns in diameter that typically branch at acute angles  (<a class="graphic graphic_picture graphicRef69801" href="/z/d/graphic/69801.html" rel="external">picture 1</a>). The production of both fusoid macroconidia (hyaline, multicellular, banana-like clusters with foot cells at the base)  (<a class="graphic graphic_picture graphicRef72385" href="/z/d/graphic/72385.html" rel="external">picture 3</a> and <a class="graphic graphic_picture graphicRef61073" href="/z/d/graphic/61073.html" rel="external">picture 4</a>), and microconidia (hyaline, unicellular, ovoid to cylindrical) are characteristic of the genus <em>Fusarium</em>. (See <a class="local">'Microscopic appearance'</a> above.)</p><p></p><p class="bulletIndent1">The characteristic appearance of <em>Fusarium</em> macroconidia is used for identification  (<a class="graphic graphic_picture graphicRef72385" href="/z/d/graphic/72385.html" rel="external">picture 3</a> and <a class="graphic graphic_picture graphicRef61073" href="/z/d/graphic/61073.html" rel="external">picture 4</a>), but species identification is difficult and often requires molecular methods or matrix-assisted laser desorption/ionization time of flight (MALDI-TOF). (See <a class="local">'Species identification'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Taxonomy</strong> – More than 300 species of <em>Fusarium</em> have been identified, but only a few cause infections in humans. Fusarium species are grouped into various phylogenetic species complexes (more than 20), 7 of which have been reported to cause significant disease in humans: <em>Fusarium solani </em>species complex (50 percent of infections), <em>Fusarium oxysporum </em>species complex, <em>Fusarium fujikuroi </em>species complex, <em>Fusarium incarnatum-equiseti </em>species complex, <em>Fusarium chlamidosporum </em>species complex, <em>Fusarium dimerum </em>species complex, and <em>Fusarium sporotrichoides </em>species complex. (See <a class="local">'Species prevalence'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathophysiology</strong> – <em>Fusarium</em> species cause invasive disease by angioinvasion and direct tissue destruction. Innate immunity plays a major role in the defense against various molds, including <em>Fusarium</em> species. Macrophages and neutrophils damage fusarial hyphae, and their effect is primed by interferon-gamma, granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and interleukin-15. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors</strong> – <em>Fusarium</em> species cause a broad spectrum of infections in humans, including superficial, locally invasive, and disseminated infections. The clinical form of infection depends upon the immune status of the host and the portal of entry of the pathogen  (<a class="graphic graphic_table graphicRef64555" href="/z/d/graphic/64555.html" rel="external">table 1</a>). (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1">Patients with compromised immune function are at high risk for invasive fusariosis, particularly in the setting of prolonged and profound neutropenia and/or severe T cell immunodeficiency, such as in patients with hematologic malignancies receiving induction chemotherapy or allogeneic hematopoietic cell transplantation. (See <a class="local">'Risk factors'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev 2007; 20:695.</a></li><li><a class="nounderline abstract_t">Wickern GM. Fusarium allergic fungal sinusitis. J Allergy Clin Immunol 1993; 92:624.</a></li><li><a class="nounderline abstract_t">Nelson PE, Dignani MC, Anaissie EJ. Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev 1994; 7:479.</a></li><li><a class="nounderline abstract_t">Evans J, Levesque D, de Lahunta A, Jensen HE. Intracranial fusariosis: a novel cause of fungal meningoencephalitis in a dog. Vet Pathol 2004; 41:510.</a></li><li><a class="nounderline abstract_t">Elvers KT, Leeming K, Moore CP, Lappin-Scott HM. Bacterial-fungal biofilms in flowing water photo-processing tanks. J Appl Microbiol 1998; 84:607.</a></li><li class="breakAll">Silveira FP, Queiroz-Telles F, Nucci M. Invasive mold infections. In: Diagnosis of fungal infections, Maertens JA, Marr KA (Eds), Informa Healthcare, 2007. p.171.</li><li><a class="nounderline abstract_t">Liu K, Howell DN, Perfect JR, Schell WA. Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces, and Acremonium species by histopathology. Am J Clin Pathol 1998; 109:45.</a></li><li><a class="nounderline abstract_t">Healy M, Reece K, Walton D, et al. Use of the Diversi Lab System for species and strain differentiation of Fusarium species isolates. J Clin Microbiol 2005; 43:5278.</a></li><li class="breakAll">Fleming RV, Anaissie EJ. Hyalohyphomycosis - Infection due to hyaline moulds. In: Diagnosis and Treatment of Human Mycoses, Hospenthal DR, Rinaldi MG (Eds), Humana Press, Totowa 2008. p.201.</li><li><a class="nounderline abstract_t">O'Donnell K, Sutton DA, Rinaldi MG, et al. Internet-accessible DNA sequence database for identifying fusaria from human and animal infections. J Clin Microbiol 2010; 48:3708.</a></li><li><a class="nounderline abstract_t">de Almeida JN Júnior, Sztajnbok J, da Silva AR Junior, et al. Rapid identification of moulds and arthroconidial yeasts from positive blood cultures by MALDI-TOF mass spectrometry. Med Mycol 2016; 54:885.</a></li><li><a class="nounderline abstract_t">Triest D, Stubbe D, De Cremer K, et al. Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of molds of the Fusarium genus. J Clin Microbiol 2015; 53:465.</a></li><li><a class="nounderline abstract_t">Alastruey-Izquierdo A, Cuenca-Estrella M, Monzón A, et al. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods. J Antimicrob Chemother 2008; 61:805.</a></li><li><a class="nounderline abstract_t">Al-Hatmi AM, Hagen F, Menken SB, et al. Global molecular epidemiology and genetic diversity of Fusarium, a significant emerging group of human opportunists from 1958 to 2015. Emerg Microbes Infect 2016; 5:e124.</a></li><li><a class="nounderline abstract_t">van Diepeningen AD, Al-Hatmi AMS, Brankovics B, de Hoog GS. Taxonomy and clinical spectra of Fusarium species: Where do we stand in 2014? Curr Clin Microbiol Rep 2014; 1:10.</a></li><li><a class="nounderline abstract_t">Balajee SA, Borman AM, Brandt ME, et al. Sequence-based identification of Aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here? J Clin Microbiol 2009; 47:877.</a></li><li><a class="nounderline abstract_t">Herkert PF, Al-Hatmi AMS, de Oliveira Salvador GL, et al. Molecular Characterization and Antifungal Susceptibility of Clinical Fusarium Species From Brazil. Front Microbiol 2019; 10:737.</a></li><li><a class="nounderline abstract_t">Tortorano AM, Prigitano A, Esposto MC, et al. European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe. Eur J Clin Microbiol Infect Dis 2014; 33:1623.</a></li><li><a class="nounderline abstract_t">Dóczi I, Gyetvai T, Kredics L, Nagy E. Involvement of Fusarium spp. in fungal keratitis. Clin Microbiol Infect 2004; 10:773.</a></li><li><a class="nounderline abstract_t">Brilhante RS, Cordeiro RA, Medrano DJ, et al. Onychomycosis in Ceará (Northeast Brazil): epidemiological and laboratory aspects. Mem Inst Oswaldo Cruz 2005; 100:131.</a></li><li><a class="nounderline abstract_t">Godoy P, Nunes E, Silva V, et al. Onychomycosis caused by Fusarium solani and Fusarium oxysporum in São Paulo, Brazil. Mycopathologia 2004; 157:287.</a></li><li><a class="nounderline abstract_t">Ninet B, Jan I, Bontems O, et al. Molecular identification of Fusarium species in onychomycoses. Dermatology 2005; 210:21.</a></li><li class="breakAll">Torres HA, Kontoyiannis DP. Hyalohyphomycoses (hyaline moulds). In: Essentials of Clinical Mycology, 2nd ed, Kauffman C, Pappas PG, Sobel JD (Eds), Springer, New York 2011. p.281.</li><li><a class="nounderline abstract_t">Krátká J, Kováciková E. The effect of temperature and age of strains of Fusarium oxysporum on its enzymatic activity. Zentralbl Bakteriol Naturwiss 1979; 134:154.</a></li><li><a class="nounderline abstract_t">Mayayo E, Pujol I, Guarro J. Experimental pathogenicity of four opportunist Fusarium species in a murine model. J Med Microbiol 1999; 48:363.</a></li><li><a class="nounderline abstract_t">Shoham S, Levitz SM. The immune response to fungal infections. Br J Haematol 2005; 129:569.</a></li><li><a class="nounderline abstract_t">Gaviria JM, van Burik JA, Dale DC, et al. Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens. J Infect Dis 1999; 179:1038.</a></li><li><a class="nounderline abstract_t">Winn RM, Gil-Lamaignere C, Roilides E, et al. Effects of interleukin-15 on antifungal responses of human polymorphonuclear leukocytes against Fusarium spp. and Scedosporium spp. Cytokine 2005; 31:1.</a></li><li><a class="nounderline abstract_t">Romani L. Immunity to fungal infections. Nat Rev Immunol 2004; 4:1.</a></li><li><a class="nounderline abstract_t">Nucci M, Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis 2002; 35:909.</a></li><li><a class="nounderline abstract_t">Rippon JW, Larson RA, Rosenthal DM, Clayman J. Disseminated cutaneous and peritoneal hyalohyphomycosis caused by Fusarium species: three cases and review of the literature. Mycopathologia 1988; 101:105.</a></li><li><a class="nounderline abstract_t">Kerr CM, Perfect JR, Craven PC, et al. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Ann Intern Med 1983; 99:334.</a></li><li><a class="nounderline abstract_t">Flynn JT, Meislich D, Kaiser BA, et al. Fusarium peritonitis in a child on peritoneal dialysis: case report and review of the literature. Perit Dial Int 1996; 16:52.</a></li><li><a class="nounderline abstract_t">Kurien M, Anandi V, Raman R, Brahmadathan KN. Maxillary sinus fusariosis in immunocompetent hosts. J Laryngol Otol 1992; 106:733.</a></li><li><a class="nounderline abstract_t">Madhavan M, Ratnakar C, Veliath AJ, et al. Primary disseminated fusarial infection. Postgrad Med J 1992; 68:143.</a></li><li><a class="nounderline abstract_t">Sander A, Beyer U, Amberg R. Systemic Fusarium oxysporum infection in an immunocompetent patient with an adult respiratory distress syndrome (ARDS) and extracorporal membrane oxygenation (ECMO). Mycoses 1998; 41:109.</a></li><li><a class="nounderline abstract_t">Murray CK, Beckius ML, McAllister K. Fusarium proliferatum superficial suppurative thrombophlebitis. Mil Med 2003; 168:426.</a></li><li><a class="nounderline abstract_t">Sturm AW, Grave W, Kwee WS. Disseminated Fusarium oxysporum infection in patient with heatstroke. Lancet 1989; 1:968.</a></li><li><a class="nounderline abstract_t">Pflugfelder SC, Flynn HW Jr, Zwickey TA, et al. Exogenous fungal endophthalmitis. Ophthalmology 1988; 95:19.</a></li><li><a class="nounderline abstract_t">Gabriele P, Hutchins RK. Fusarium endophthalmitis in an intravenous drug abuser. Am J Ophthalmol 1996; 122:119.</a></li><li><a class="nounderline abstract_t">Jakle C, Leek JC, Olson DA, Robbins DL. Septic arthritis due to Fusarium solani. J Rheumatol 1983; 10:151.</a></li><li><a class="nounderline abstract_t">Bourguignon RL, Walsh AF, Flynn JC, et al. Fusarium species osteomyelitis. Case report. J Bone Joint Surg Am 1976; 58:722.</a></li><li><a class="nounderline abstract_t">Chang DC, Grant GB, O'Donnell K, et al. Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA 2006; 296:953.</a></li><li><a class="nounderline abstract_t">Khor WB, Aung T, Saw SM, et al. An outbreak of Fusarium keratitis associated with contact lens wear in Singapore. JAMA 2006; 295:2867.</a></li><li><a class="nounderline abstract_t">Patel A, Hammersmith K. Contact lens-related microbial keratitis: recent outbreaks. Curr Opin Ophthalmol 2008; 19:302.</a></li><li><a class="nounderline abstract_t">Saw SM, Ooi PL, Tan DT, et al. Risk factors for contact lens-related fusarium keratitis: a case-control study in Singapore. Arch Ophthalmol 2007; 125:611.</a></li><li><a class="nounderline abstract_t">Bullock JD, Elder BL, Khamis HJ, Warwar RE. Effects of time, temperature, and storage container on the growth of Fusarium species: implications for the worldwide Fusarium keratitis epidemic of 2004-2006. Arch Ophthalmol 2011; 129:133.</a></li><li><a class="nounderline abstract_t">Bullock JD, Elder BL, Warwar RE, et al. Mechanism of drug failure in fusarium keratitis, 2004-2006. N Engl J Med 2014; 370:88.</a></li><li><a class="nounderline abstract_t">Yildiz EH, Abdalla YF, Elsahn AF, et al. Update on fungal keratitis from 1999 to 2008. Cornea 2010; 29:1406.</a></li><li><a class="nounderline abstract_t">Tanure MA, Cohen EJ, Sudesh S, et al. Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea 2000; 19:307.</a></li><li><a class="nounderline abstract_t">Rosa RH Jr, Miller D, Alfonso EC. The changing spectrum of fungal keratitis in south Florida. Ophthalmology 1994; 101:1005.</a></li><li><a class="nounderline abstract_t">Guilhermetti E, Takahachi G, Shinobu CS, Svidzinski TI. Fusarium spp. as agents of onychomycosis in immunocompetent hosts. Int J Dermatol 2007; 46:822.</a></li><li><a class="nounderline abstract_t">Hilmioğlu-Polat S, Metin DY, Inci R, et al. Non-dermatophytic molds as agents of onychomycosis in Izmir, Turkey - a prospective study. Mycopathologia 2005; 160:125.</a></li><li><a class="nounderline abstract_t">Romano C, Papini M, Ghilardi A, Gianni C. Onychomycosis in children: a survey of 46 cases. Mycoses 2005; 48:430.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Fungal meningitis outbreak associated with procedures performed under epidural anesthesia in Matamoros, Mexico. https://www.cdc.gov/hai/outbreaks/meningitis-epidural-anesthesia.html#:~:text=Early%20testing%20and%20treatment%2C%20especially,mild%20or%20absent%20at%20first. (Accessed on June 14, 2023).</li><li class="breakAll">Interim recommendations for diagnosis and management of fungal meningitis associated with epidural anesthesia administered in Matamoros, Mexico. https://funguseducationhub.org/wp-content/uploads/2023/06/interim-recommendations-Matamoros-FM-outbreak-6_09_23.pdf (Accessed on June 14, 2023).</li><li><a class="nounderline abstract_t">Moretti ML, Busso-Lopes AF, Tararam CA, et al. Airborne transmission of invasive fusariosis in patients with hematologic malignancies. PLoS One 2018; 13:e0196426.</a></li><li><a class="nounderline abstract_t">Anaissie EJ, Kuchar RT, Rex JH, et al. Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections. Clin Infect Dis 2001; 33:1871.</a></li><li><a class="nounderline abstract_t">Nucci M, Varon AG, Garnica M, et al. Increased incidence of invasive fusariosis with cutaneous portal of entry, Brazil. Emerg Infect Dis 2013; 19:1567.</a></li><li><a class="nounderline abstract_t">Varon AG, Nouer SA, Barreiros G, et al. Superficial skin lesions positive for Fusarium are associated with subsequent development of invasive fusariosis. J Infect 2014; 68:85.</a></li><li><a class="nounderline abstract_t">Carlesse F, Amaral AC, Gonçalves SS, et al. Outbreak of Fusarium oxysporum infections in children with cancer: an experience with 7 episodes of catheter-related fungemia. Antimicrob Resist Infect Control 2017; 6:93.</a></li><li><a class="nounderline abstract_t">Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood 1997; 90:999.</a></li><li><a class="nounderline abstract_t">Kontoyiannis DP, Marr KA, Park BJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010; 50:1091.</a></li><li><a class="nounderline abstract_t">Pagano L, Caira M, Nosari A, et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis 2007; 45:1161.</a></li><li><a class="nounderline abstract_t">Pagano L, Caira M, Candoni A, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006; 91:1068.</a></li><li><a class="nounderline abstract_t">Nucci M, Garnica M, Gloria AB, et al. Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil. Clin Microbiol Infect 2013; 19:745.</a></li><li><a class="nounderline abstract_t">Souza L, Nouér SA, Morales H, et al. Epidemiology of invasive fungal disease in haematologic patients. Mycoses 2021; 64:252.</a></li><li><a class="nounderline abstract_t">Nucci M, Anaissie EJ, Queiroz-Telles F, et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer 2003; 98:315.</a></li><li><a class="nounderline abstract_t">Garnica M, da Cunha MO, Portugal R, et al. Risk factors for invasive fusariosis in patients with acute myeloid leukemia and in hematopoietic cell transplant recipients. Clin Infect Dis 2015; 60:875.</a></li><li><a class="nounderline abstract_t">Chan TS, Au-Yeung R, Chim CS, et al. Disseminated fusarium infection after ibrutinib therapy in chronic lymphocytic leukaemia. Ann Hematol 2017; 96:871.</a></li><li><a class="nounderline abstract_t">Nucci M, Marr KA, Queiroz-Telles F, et al. Fusarium infection in hematopoietic stem cell transplant recipients. Clin Infect Dis 2004; 38:1237.</a></li><li><a class="nounderline abstract_t">Sampathkumar P, Paya CV. Fusarium infection after solid-organ transplantation. Clin Infect Dis 2001; 32:1237.</a></li><li><a class="nounderline abstract_t">Abbara S, Freeman AF, Cohen JF, et al. Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome. J Clin Immunol 2023; 43:647.</a></li><li><a class="nounderline abstract_t">Gangneux JP, Dannaoui E, Fekkar A, et al. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study. Lancet Respir Med 2022; 10:180.</a></li></ol></div><div id="topicVersionRevision">Topic 2426 Version 26.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17934079" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Fusarium infections in immunocompromised patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8409122" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Fusarium allergic fungal sinusitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7834602" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Taxonomy, biology, and clinical aspects of Fusarium species.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15347824" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Intracranial fusariosis: a novel cause of fungal meningoencephalitis in a dog.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9633659" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Bacterial-fungal biofilms in flowing water photo-processing tanks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9633659" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Bacterial-fungal biofilms in flowing water photo-processing tanks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9426517" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces, and Acremonium species by histopathology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16207996" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Use of the Diversi Lab System for species and strain differentiation of Fusarium species isolates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16207996" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Use of the Diversi Lab System for species and strain differentiation of Fusarium species isolates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20686083" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Internet-accessible DNA sequence database for identifying fusaria from human and animal infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27317582" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Rapid identification of moulds and arthroconidial yeasts from positive blood cultures by MALDI-TOF mass spectrometry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25411180" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of molds of the Fusarium genus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18263569" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27924809" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Global molecular epidemiology and genetic diversity of Fusarium, a significant emerging group of human opportunists from 1958 to 2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Taxonomy and clinical spectra of Fusarium species: Where do we stand in 2014?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19073865" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Sequence-based identification of Aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31024507" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Molecular Characterization and Antifungal Susceptibility of Clinical Fusarium Species From Brazil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24791951" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15355406" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Involvement of Fusarium spp. in fungal keratitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16021299" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Onychomycosis in Ceará(Northeast Brazil): epidemiological and laboratory aspects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15180157" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Onychomycosis caused by Fusarium solani and Fusarium oxysporum in São Paulo, Brazil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15604540" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Molecular identification of Fusarium species in onychomycoses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15604540" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Molecular identification of Fusarium species in onychomycoses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/473966" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : The effect of temperature and age of strains of Fusarium oxysporum on its enzymatic activity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10509478" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Experimental pathogenicity of four opportunist Fusarium species in a murine model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15916679" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : The immune response to fungal infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10068606" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15935692" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Effects of interleukin-15 on antifungal responses of human polymorphonuclear leukocytes against Fusarium spp. and Scedosporium spp.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14661066" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Immunity to fungal infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12355377" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3278237" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Disseminated cutaneous and peritoneal hyalohyphomycosis caused by Fusarium species: three cases and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6351688" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8616174" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Fusarium peritonitis in a child on peritoneal dialysis: case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1402369" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Maxillary sinus fusariosis in immunocompetent hosts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1570258" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Primary disseminated fusarial infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9670761" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Systemic Fusarium oxysporum infection in an immunocompetent patient with an adult respiratory distress syndrome (ARDS) and extracorporal membrane oxygenation (ECMO).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12775184" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Fusarium proliferatum superficial suppurative thrombophlebitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2565468" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Disseminated Fusarium oxysporum infection in patient with heatstroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3257818" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Exogenous fungal endophthalmitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8659586" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Fusarium endophthalmitis in an intravenous drug abuser.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6842474" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Septic arthritis due to Fusarium solani.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/932073" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Fusarium species osteomyelitis. Case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16926355" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16804153" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : An outbreak of Fusarium keratitis associated with contact lens wear in Singapore.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18545011" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Contact lens-related microbial keratitis: recent outbreaks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17502498" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Risk factors for contact lens-related fusarium keratitis: a case-control study in Singapore.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21320955" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Effects of time, temperature, and storage container on the growth of Fusarium species: implications for the worldwide Fusarium keratitis epidemic of 2004-2006.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24382083" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Mechanism of drug failure in fusarium keratitis, 2004-2006.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20847685" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Update on fungal keratitis from 1999 to 2008.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10832689" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8008340" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : The changing spectrum of fungal keratitis in south Florida.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17651164" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Fusarium spp. as agents of onychomycosis in immunocompetent hosts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16170607" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Non-dermatophytic molds as agents of onychomycosis in Izmir, Turkey - a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16262881" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Onychomycosis in children: a survey of 46 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16262881" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Onychomycosis in children: a survey of 46 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16262881" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Onychomycosis in children: a survey of 46 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29698435" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Airborne transmission of invasive fusariosis in patients with hematologic malignancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11692299" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24050318" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Increased incidence of invasive fusariosis with cutaneous portal of entry, Brazil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23994063" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Superficial skin lesions positive for Fusarium are associated with subsequent development of invasive fusariosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28912948" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Outbreak of Fusarium oxysporum infections in children with cancer: an experience with 7 episodes of catheter-related fungemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9242529" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20218877" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17918077" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16885047" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23009319" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33141969" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Epidemiology of invasive fungal disease in haematologic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12872351" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25425628" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Risk factors for invasive fusariosis in patients with acute myeloid leukemia and in hematopoietic cell transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28184982" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Disseminated fusarium infection after ibrutinib therapy in chronic lymphocytic leukaemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15127334" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Fusarium infection in hematopoietic stem cell transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11283817" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Fusarium infection after solid-organ transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36504258" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34843666" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
